Abstract:OBJECTIVE:To explore the feasibility of IGF2 imprinting system in target gene therapy for tumors.METHODS:The mouse H19 enhancer, DMD and promoter H19 were amplified by PCR from mouse genomic DNA and then cloned into the plasmid pDC312. The EGFP and DT-A fragments were amplified by PCR and cloned into the recombinant plasmid, and then the shuttle plasmid were transfected into HEK293 cells together with the adenoviral vector Ad5, namely, Ad-EGFP and Ad-DT-A. Adenovirus hexon gene expression was applied to confirm the presence of adenovirus infections. The effect of the IGF2 imprinting system was tested by fluorescence microscopy. RT-PCR and Western blotting after transfection of the recombinant adenoviral vectors into cancer cells were used to show loss of IGF2 imprinting (LOI) and maintenance of IGF2 imprinting (MOI), respectively. The anti-tumor effect was assessed by MTT and flow cytometry after the HCT-8 (LOI). Human breast cancer cell line MCF-7 (MOI) and human normal gastric epithelial GES-1 (MOI) cell line were transfected with Ad-DT-A in vitro. The anti-tumor effect was detected by injecting the Ad-DT-A in nude mice carrying HCT-8 tumors.RESULTS:The expression of EGFP protein, DT-A mRNA and DT-A protein were seen to be positive only in the HCT-8 tumor cell line. Infection with Ad-DT-A resulted in obviously growth inhibition in HCT-8 cells (75.4 ± 6.4)% compared with that in the control group, and increased the percentage of apoptosis in the HCT-8 cells (20.8 ± 5.9)%. The anti-tumor effect was further confirmed by injecting the recombinant adenoviruses in HCT-8 tumor-bearing nude mice, and the results showed that the Ad-DT-A inhibited the tumor growth, with on inhibition rate of 36.4%.CONCLUSIONS:The recombinant adenoviruses carrying IGF2 imprinting system and DT-A gene have been successfully constructed, while Ad-DT-A can effectively kill the tumor cells showing loss of IGF2 imprinting. It might play an important role in future target gene therapy against malignant tumors based on loss of IGF2 imprinting.

Construction and identification of recombinant adenovirus carrying IGF2 imprinting system

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

[Effect of Recombinant Adenovirus Ad-DT-A in Targeted Therapy for Malignant Cancer Cell Lines with Loss of IGF2 Imprinting].

Construction and Expression of the Eukaryotic Expression Vector Pci-Chil-2-egfp and Enhancement of AIV Vaccine

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Construction of A Lentiviral Vector Simultaneously Expressing Active IGF1, EGF and FGF2

Gene Therapy for Cancer Through Adenovirus Vector-Mediated Expression of the Ad5 Early Region Gene 1A Based on Loss of IGF2 Imprinting

Targeted tumor gene therapy based on loss of IGF2 imprinting.

Construction and Identification of Recombinant Adenovirus Harboring the GIP-Human Insulin Gene

Gene Therapy for Human Colorectal Cancer Cell Lines with Recombinant Adenovirus 5 Based on Loss of the Insulin-Like Growth Factor 2 Imprinting.

[Construction and Identification of Recombinant Adenovirus Expressing Rat Proteoglycan II].

Construction and identification of recombinant adenovirus vector with the fusion gene GC2A:GM-SCF and LMP2A

Gene Therapy for Colorectal Cancer by an Oncolytic Adenovirus That Targets Loss of the Insulin-Like Growth Factor 2 Imprinting System

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes

Construction and ~(125)I Induced-expression in EJ Cells of Lentiviral Vector Carrying Radiation-responsive Promoter and CD Gene

Targeted therapy for malignant cancer mediated by adenovirus vector expressing diphtheria toxin a based on loss of IGF2 imprinting

Construction of Htert and Cox-2 Dependent Oncolytic Adenovirus

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Construction of Adenovirus Vector with Human Interleukin 10 and Its Expression in Vascular Smooth Muscle Cells

Construction and Identification of Five Mutants of Hil-18 in Expression Plasmid and Their Expression in BxPC-3 Cells

Construction of Recombinant miR-192-expressing Adenovirus and Analysis of its Expression in Hepatocyte